Survivin Polyclonal Antibody

$Formalin-fixed human oral squamous cell carcinoma labeled with Anti-Survivin Polyclonal Antibody, Cy3 conjugated (bs-0615R-Cy3) used at 1:200 dilution for 40 minutes at 37\u00b0C, followed by DAPI staining$

Formalin-fixed human oral squamous cell carcinoma labeled with Anti-Survivin Polyclonal Antibody, Cy3 conjugated (bs-0615R-Cy3) used at 1:200 dilution for 40 minutes at 37\u00b0C, followed by DAPI staining

Human Gastric Cancer Cells labeled with Anti-Survivin Polyclonal Antibody, Unconjugated (bs-0615R) at 1:300, followed by conjugation to the secondary antibody and DAB staining

Formalin-fixed and paraffin embedded human colon carcinoma labeled with Anti-Survivin Polyclonal Antibody, Unconjugated (bs-0615R) at 1:200, followed by conjugation to the secondary antibody and DAB staining

$Formalin-fixed and paraffin embedded human oral squamous cell carcinoma labeled with Rabbit Anti-Survivin Polyclonal Antibody, Unconjugated (bs-0615R) at 1:200 followed by Goat Anti-Rabbit IgG, FITC conjugated (bs-0295G-FITC) used at 1:300 dilution for 40 minutes at 37\u00b0C.$

Formalin-fixed and paraffin embedded human oral squamous cell carcinoma labeled with Rabbit Anti-Survivin Polyclonal Antibody, Unconjugated (bs-0615R) at 1:200 followed by Goat Anti-Rabbit IgG, FITC conjugated (bs-0295G-FITC) used at 1:300 dilution for 40 minutes at 37\u00b0C.

U251 cells probed with Survivin Polyclonal Antibody, Unconjugated (bs-0615R) for 30 minutes followed by incubation with a conjugated secondary (FITC Conjugated) (green) for 30 minutes compared to control cells (blue), secondary only (light blue) and isotype control (orange).

Mouse smail intestine lysates probed with Survivin Polyclonal Antibody, Unconjugated (bs-0615R) at 1:300 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:10000 for 60 min at 37˚C.

Applications

WB
ELISA
FCM
IHC-P
IHC-F
IF(IHC-P)
IF(IHC-F)
IF(ICC)

Reactivity

Human
Mouse

Predicted Reactivity

Rat
Dog
Cow
Pig
Horse
Guinea Pig

Overview
Catalog #	bs-0615R
Product Name	Survivin Polyclonal Antibody
Applications	WB, ELISA, FCM, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC)
Reactivity	Human, Mouse
Predicted Reactivity	Rat, Dog, Cow, Pig, Horse, Guinea Pig
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	KLH conjugated synthetic peptide derived from human Survivin
Immunogen Range	85-142/142
Clonality	Polyclonal
Isotype	IgG
Concentration	1ug/ul
Purification	Purified by Protein A.
Storage Buffer	0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage Condition	Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Target
Gene ID	332
Swiss Prot	O15392
Subcellular location	Cytoplasm, Nucleus
Synonyms	API4; EPR-1; Baculoviral IAP repeat-containing protein 5; Apoptosis inhibitor 4; Apoptosis inhibitor survivin; BIRC5; IAP4
Background	Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis. Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis. Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with polymerized microtubules. The complex with RAN plays a role in mitotic spindle formation by serving as a physical scaffold to help deliver the RAN effector molecule TPX2 to microtubules. May counteract a default induction of apoptosis in G2/M phase. The acetylated form represses STAT3 transactivation of target gene promoters. May play a role in neoplasia. Inhibitor of CASP3 and CASP7. Isoform 2 and isoform 3 do not appear to play vital roles in mitosis. Isoform 3 shows a marked reduction in its anti-apoptotic effects when compared with the displayed wild-type isoform.
Application Dilution
WB	1:300-5000
ELISA	1:500-1000
FCM	1:20-100
IHC-P	1:200-400
IHC-F	1:100-500
IF(IHC-P)	1:50-200
IF(IHC-F)	1:50-200
IF(ICC)	1:50-200